Physician profile
David Singer
NPI 1164531745
$624.14
in general payments reported to CMS, 2019-2025
10 companies · $14.13 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.77 · 2020: $214 · 2022: $107 · 2023: $131 · 2024: $61.54 · 2025: $14.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $206.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $248.17 | 2019-2020 | |
| Mentor Worldwide LLC | $125.94 | 2019-2022 | |
| Leo Pharma INC. | $61.54 | 2024 | Adbry |
| Convatec INC. | $38.55 | 2023 | |
| Bioventus LLC | $37.76 | 2023 | |
| Janssen Biotech, INC. | $33.27 | 2023 | Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $24.19 | 2022 | |
| Sun Pharmaceutical Industries INC. | $21.52 | 2023 | Ilumya |
| Tela Bio, INC. | $19.07 | 2022 | |
| Davol INC. | $14.13 | 2025 | Arista |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Singer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.